{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:17:23Z","timestamp":1790853443122,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,23]]},"DOI":"10.7759\/cureus.19831","type":"journal-article","created":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T13:10:48Z","timestamp":1637673048000},"source":"Crossref","is-referenced-by-count":11,"title":["A Study on the Efficacy of a Naloxone Training Program"],"prefix":"10.7759","author":[{"given":"Gillian A","family":"Beauchamp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoonani M","family":"Cuadrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bennie B","family":"Eliason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chase L","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron T","family":"Fedor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Grantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marna Rayl","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"CDC WONDER. (2018). https.\/\/wonder.cdc.gov\/."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2012.759858","article-title":"Nonmedical use of prescription ADHD stimulants and preexisting patterns of drug abuse","volume":"32","author":"Sweeney CT","year":"2013","unstructured":"Sweeney CT, Sembower MA, Ertischek MD, Shiffman S, Schnoll SH. Nonmedical use of prescription ADHD stimulants and preexisting patterns of drug abuse. J Addict Dis. 2013, 32:1-10. 10.1080\/10550887.2012.759858","journal-title":"J Addict Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.12.026","article-title":"Predictors of transition to heroin use among initially non-opioid dependent illicit pharmaceutical opioid users: a natural history study","volume":"1","author":"Carlson RG","year":"2016","unstructured":"Carlson RG, Nahhas RW, Martins SS, Daniulaityte R. Predictors of transition to heroin use among initially non-opioid dependent illicit pharmaceutical opioid users: a natural history study. Drug Alcohol Depend. 2016, 1:127-134. 10.1016\/j.drugalcdep.2015.12.026","journal-title":"Drug Alcohol Depend"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6643e1","article-title":"Deaths involving fentanyl, fentanyl analogs, and U-47700 - 10 states, July-December 2016","volume":"66","author":"O'Donnell JK","year":"2017","unstructured":"O'Donnell JK, Halpin J, Mattson CL, Goldberger BA, Gladden RM. Deaths involving fentanyl, fentanyl analogs, and U-47700 - 10 states, July-December 2016. MMWR Morb Mortal Wkly Rep. 2017, 66:1197-1202. 10.15585\/mmwr.mm6643e1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2217\/pmt-2017-0060","article-title":"Pharmacokinetic properties of intranasal and injectable formulations of naloxone for community use: a systematic review","volume":"8","author":"Ryan SA","year":"2018","unstructured":"Ryan SA, Dunne RB. Pharmacokinetic properties of intranasal and injectable formulations of naloxone for community use: a systematic review. Pain Manag. 2018, 8:231-245. 10.2217\/pmt-2017-0060","journal-title":"Pain Manag"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7326\/M17-2224","article-title":"Management of suspected opioid overdose with naloxone in out-of-hospital settings: a systematic review","volume":"19","author":"Chou R","year":"2017","unstructured":"Chou R, Korthuis PT, McCarty D, et al.. Management of suspected opioid overdose with naloxone in out-of-hospital settings: a systematic review. Ann Intern Med. 2017, 19:867-875. 10.7326\/M17-2224","journal-title":"Ann Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12696","article-title":"AAPM 2015 Annual Meeting abstracts. Naloxone 0.4 mg bioavailability following a single injection with a novel naloxone auto-injector, EVZIO\u00ae, in healthy adults, with reference to a 1 mL standard syringe and intramuscular needle","volume":"16","author":"Edwards ES","year":"2015","unstructured":"Edwards ES, Gunn R, Kelley G, Smith A, Goldwater R. AAPM 2015 Annual Meeting abstracts. Naloxone 0.4 mg bioavailability following a single injection with a novel naloxone auto-injector, EVZIO\u00ae, in healthy adults, with reference to a 1 mL standard syringe and intramuscular needle. Pain Med. 2015, 16:558-622. 10.1111\/pme.12696","journal-title":"Pain Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.759","article-title":"Pharmacokinetic properties and human use characteristics of an FDA-approved intranasal naloxone product for the treatment of opioid overdose","volume":"56","author":"Krieter P","year":"2016","unstructured":"Krieter P, Chiang N, Gyaw S, et al.. Pharmacokinetic properties and human use characteristics of an FDA-approved intranasal naloxone product for the treatment of opioid overdose. J Clin Pharmacol. 2016, 56:1243-1253. 10.1002\/jcph.759","journal-title":"J Clin Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2017.1334637","article-title":"Use of naloxone nasal spray 4\u2009mg in the community setting: a survey of use by community organizations","volume":"34","author":"Avetian GK","year":"2018","unstructured":"Avetian GK, Fiuty P, Mazzella S, Koppa D, Heye V, Hebbar P. Use of naloxone nasal spray 4\u2009mg in the community setting: a survey of use by community organizations. Curr Med Res Opin. 2018, 34:573-576. 10.1080\/03007995.2017.1334637","journal-title":"Curr Med Res Opin"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3109\/10903127.2011.569854","article-title":"No deaths associated with patient refusal of transport after naloxone-reversed opioid overdose","volume":"15","author":"Wampler DA","year":"2011","unstructured":"Wampler DA, Molina DK, McManus J, Laws P, Manifold CA. No deaths associated with patient refusal of transport after naloxone-reversed opioid overdose. Prehosp Emerg Care. 2011, 15:320-324. 10.3109\/10903127.2011.569854","journal-title":"Prehosp Emerg Care"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020033","article-title":"Regional variation in states' naloxone accessibility laws in association with opioid overdose death rates-Observational study (STROBE compliant)","volume":"29","author":"You HS","year":"2020","unstructured":"You HS, Ha J, Kang CY, et al.. Regional variation in states' naloxone accessibility laws in association with opioid overdose death rates-Observational study (STROBE compliant). Medicine (Baltimore). 2020, 29:e20033. 10.1097\/MD.0000000000020033","journal-title":"Medicine (Baltimore)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.5388","article-title":"Availability and cost of naloxone nasal spray at pharmacies in Philadelphia, Pennsylvania, 2017","volume":"5","author":"Guadamuz JS","year":"2019","unstructured":"Guadamuz JS, Alexander GC, Chaudhri T, Trotzky-Sirr R, Qato DM. Availability and cost of naloxone nasal spray at pharmacies in Philadelphia, Pennsylvania, 2017. JAMA Netw Open. 2019, 5:e195388. 10.1001\/jamanetworkopen.2019.5388","journal-title":"JAMA Netw Open"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2009.01.003","article-title":"Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA","volume":"21","author":"Wagner KD","year":"2010","unstructured":"Wagner KD, Valente TW, Casanova M, et al.. Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA. Int J Drug Policy. 2010, 21:186-193. 10.1016\/j.drugpo.2009.01.003","journal-title":"Int J Drug Policy"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/00063110-200402000-00004","article-title":"Adverse events after naloxone treatment of episodes of suspected acute opioid overdose","volume":"11","author":"Buajordet I","year":"2004","unstructured":"Buajordet I, Naess AC, Jacobsen D, Br\u00f8rs O. Adverse events after naloxone treatment of episodes of suspected acute opioid overdose. Eur J Emerg Med. 2004, 11:19-23. 10.1097\/00063110-200402000-00004","journal-title":"Eur J Emerg Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3109\/15563659609013811","article-title":"Naloxone--for intoxications with intravenous heroin and heroin mixtures--harmless or hazardous? A prospective clinical study","volume":"34","author":"Osterwalder JJ","year":"1996","unstructured":"Osterwalder JJ. Naloxone--for intoxications with intravenous heroin and heroin mixtures--harmless or hazardous? A prospective clinical study. J Toxicol Clin Toxicol. 1996, 34:409-416. 10.3109\/15563659609013811","journal-title":"J Toxicol Clin Toxicol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.5811\/westjem.2017.1.33054","article-title":"Prevalence of homelessness in the emergency department setting","volume":"18","author":"Feldman BJ","year":"2017","unstructured":"Feldman BJ, Calogero CG, Elsayed KS, et al.. Prevalence of homelessness in the emergency department setting. West J Emerg Med. 2017, 18:366-372. 10.5811\/westjem.2017.1.33054","journal-title":"West J Emerg Med"},{"key":"ref17","unstructured":"2014 National Survey on Drug Use and Health. Detailed Tables. (2015). https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/NSDUH-DetTabs2014\/NSDUH-DetTabs2014.pdf."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/dar.12680","article-title":"Does training people to administer take-home naloxone increase their knowledge? Evidence from Australian programs","volume":"37","author":"Dietze PM","year":"2018","unstructured":"Dietze PM, Draper B, Olsen A, et al.. Does training people to administer take-home naloxone increase their knowledge? Evidence from Australian programs. Drug Alcohol Rev. 2018, 37:472-479. 10.1111\/dar.12680","journal-title":"Drug Alcohol Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2016.303141","article-title":"Evaluation of the overdose education and naloxone distribution program of the Baltimore Student Harm Reduction Coalition","volume":"106","author":"Lewis DA","year":"2016","unstructured":"Lewis DA, Park JN, Vail L, Sine M, Welsh C, Sherman SG. Evaluation of the overdose education and naloxone distribution program of the Baltimore Student Harm Reduction Coalition. Am J Public Health. 2016, 106:1243-1246. 10.2105\/AJPH.2016.303141","journal-title":"Am J Public Health"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/JAN.0000000000000231","article-title":"Opioid overdose and naloxone kit distribution: a quality assurance educational program in the primary care setting","volume":"29","author":"Lockett TL","year":"2018","unstructured":"Lockett TL, Hickman KL, Fils-Guerrier BJ, Lomonaco M, Maye JP, Rossiter AG. Opioid overdose and naloxone kit distribution: a quality assurance educational program in the primary care setting. J Addict Nurs. 2018, 29:157-162. 10.1097\/JAN.0000000000000231","journal-title":"J Addict Nurs"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris PA","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009, 42:377-381. 10.1016\/j.jbi.2008.08.010","journal-title":"J Biomed Inform"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris PA","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, et al.. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019, 95:103208. 10.1016\/j.jbi.2019.103208","journal-title":"J Biomed Inform"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.06.023","article-title":"High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants","volume":"1","author":"Barocas JA","year":"2015","unstructured":"Barocas JA, Baker L, Hull SJ, Stokes S, Westergaard RP. High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants. Drug Alcohol Depend. 2015, 1:283-286. 10.1016\/j.drugalcdep.2015.06.023","journal-title":"Drug Alcohol Depend"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1080\/10550880902772423","article-title":"Preventing death among the recently incarcerated: an argument for naloxone prescription before release","volume":"28","author":"Wakeman SE","year":"2009","unstructured":"Wakeman SE, Bowman SE, McKenzie M, Jeronimo A, Rich JD. Preventing death among the recently incarcerated: an argument for naloxone prescription before release. J Addict Dis. 2009, 28:124-129. 10.1080\/10550880902772423","journal-title":"J Addict Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2008.03.002","article-title":"Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives","volume":"20","author":"Tobin KE","year":"2009","unstructured":"Tobin KE, Sherman SG, Beilenson P, Welsh C, Latkin CA. Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives. Int J Drug Policy. 2009, 20:131-136. 10.1016\/j.drugpo.2008.03.002","journal-title":"Int J Drug Policy"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-016-0113-2","article-title":"Factors associated with knowledge of a Good Samaritan Law among young adults who use prescription opioids non-medically","volume":"13","author":"Evans TI","year":"2016","unstructured":"Evans TI, Hadland SE, Clark MA, Green TC, Marshall BD. Factors associated with knowledge of a Good Samaritan Law among young adults who use prescription opioids non-medically. Harm Reduct J. 2016, 13:24. 10.1186\/s12954-016-0113-2","journal-title":"Harm Reduct J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/72343-a-study-on-the-efficacy-of-a-naloxone-training-program","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:31:12Z","timestamp":1707507072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/72343-a-study-on-the-efficacy-of-a-naloxone-training-program"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,23]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.19831","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,23]]}}}